SCHEMBL10222977

SCHEMBL10222977

CCCCN(C)c1cc(C(=O)OC)cc(S(=O)(=O)/N=C\N(C)C)c1Oc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ SLC12A2 P55011 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ LPAR1 Q92633 1/20 0.35
▸ LPAR5 Q9H1C0 1/20 0.35
▸ AQP1 P29972 1/20 0.35
▸ PTGS2 P35354 3/20 0.34
▸ MAPT P10636 3/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574197 0.93 ALDH1A1 (0.40) LMNAALDH1A1TSHRKDM4EUSP2
SCHEMBL574196 0.93 ALDH1A1 (0.40) LMNAALDH1A1TSHRKDM4EUSP2
SCHEMBL573815 0.91 LMNA (0.39) LMNAALDH1A1TSHRKDM4EUSP2
SCHEMBL573814 0.91 LMNA (0.39) LMNAALDH1A1TSHRKDM4EUSP2
SCHEMBL572943 0.91 LMNA (0.39) LMNAALDH1A1TSHRKDM4EUSP2
SCHEMBL572944 0.91 LMNA (0.39) LMNAALDH1A1TSHRKDM4EUSP2
SCHEMBL10224228 0.91 LMNA (0.39) LMNAALDH1A1TSHRKDM4EUSP2
SCHEMBL573998 0.91 LMNA (0.38) LMNAALDH1A1TSHRKDM4EUSP2
SCHEMBL573997 0.91 LMNA (0.38) LMNAALDH1A1TSHRKDM4EUSP2
SCHEMBL572715 0.90 ALDH1A1 (0.39) LMNAALDH1A1TSHRKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback